Coming to terms with Vietnam: The Viet/American Cervical Cancer Prevention Project

Diagnostic Cytopathology

Volumn 33, Issue 5, 2005, Pages 344-351

  Suba, Eric J ^a   Donnelly, Amber D ^b   Furia, Lisa M ^c   Huynh, My Linh D ^d   Raab, Stephen S ^e,f  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^f Viet/American Cervical Cancer Prevention Project   (United States)

Author keywords

Cervical cancer; Developing countries; Ethics; Vietnam; War

Indexed keywords

CANCER PREVENTION; CANCER SCREENING; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; ETHICS; HUMAN; PAPANICOLAOU TEST; POLITICS; PRIORITY JOURNAL; PUBLIC HEALTH; QUALITY CONTROL; UNITED STATES; UTERINE CERVIX CANCER; VIET NAM; WAR; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; INTERNATIONAL COOPERATION; MASS SCREENING; PAPILLOMAVIRIDAE; PROGRAM DEVELOPMENT; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; VIETNAM;

EID: 27744593120     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/dc.20284     Document Type: Conference Paper

References (57)

1. Huynh MLD, Raab SS, Suba EJ. Association between war and cervical cancer among Vietnamese women. Int J Cancer 2004;110:775-777.
2. Suba EJ, Hung NC, Due NB, Raab SS on behalf of the Viel/American Cervical Cancer Prevention Project. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam. Cancer 2001;91:928-939.
3. Suba EJ, Raab SS on behalf of the Viet/American Cervical Cancer Prevention Project. Papanicolaou screening in developing countries: an idea whose time has come. Am J Clin Pathol 2004;121:315-320.
4. Geisinger KR. Obstacles to reducing cervical cancer in Vietnam. Editorial. Am J Clin Pathol 2004;121:313-314.
5. Marin P. Coming to terms with Vietnam: settling our moral debts. Harper's Magazine, December, 1980, 41-56.
6. Reprinted in: Freedom and its discontents: reflections on four decades of American moral experience. Hanover, NH: Steerforth Press; 1995.
7. Jamison DT, Mosley H, Bobadilla J, Measham AR, editors. Disease control priorities in developing countries. New York: Oxford University Press; 1993.
8. Chirenje ZM, Rusakaniko S, Kirumbi L, et al. Situation analysis for cervical cancer diagnosis and treatment in east, central and southern African countries. Bull World Health Organ 2001;79:127-132.
9. Nascimenlo CM, Eluf-Neto J, Rego RA. Pap test coverage in Sao Paulo municipality and characteristics of the women tested. Bull Pan Am Health Organ 1996;30:302-312.
10. Gajalakshmi CK, Krishnamurthi S, Ananth R, Shanla V. Cervical cancer screening in Tamilnadu, India: a feasibility study of training the village health nurse. Cancer Causes Control 1996;7:520-524.
11. Suba EJ, Raab SS on behalf of the Viet/American Cervical Cancer Prevention Project. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam (author reply). Cancer 2002;94:2314-2316.
12. Vizcaino AP, Moreno V, Bosch FX, et al. International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Im J Cancer 2000;86:429-435.
13. Nguyen VP, Knodel J, Mai VC, Hoang X. Fertilily and family planning in Vietnam: evidence from the 1994 inler-censal demographic survey. Stud Farn Plann 1996;27:1-17.
14. Feachem R, Kjellstrom T, Murray C, Over M, Phillips M, editors. The health of adults in the developing world. New York: Oxford University Press; 1992.
15. Wang L. Developing countries put cervical cancer tests to the test. J Natl Cancer Inst 2002;94:245-247.
16. Anh PT, Due NB. The situation with cancer control in Vietnam. Jpn J Clin Oncol 2002;32(Suppl):S92-S97.
17. Hung NC, Due NB. Establishment of the national cancer control program in Vietnam. Medical Journal of Ho Chi Minh City. Special Issue on Cancer 1997;1-9.
18. Due NB, Hung NC. Establishment of the national cancer control program in Vietnam 2001-2005. Proceedings of the Ha Noi 2000 International Cancer Control Conference, August 1-9, 2000.
19. Suba EJ, Raab SS. Feasibility of cytology-based cervical cancer screening in rural Cameroon (letter). Acta Cytol 2003;47:948-949.
20. Suba EJ on behalf of the Viet/American Cervical Cancer Prevention Project. Crossing the quality chasm: a requirement for successful cervical cancer prevention in developing countries. Review. Clin Lab Med 2004;24(4):945-963.
21. World Medical Association. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. Available at: http://www.wma.net/e/policy/pdf/17c.pdf [accessed on March 29, 2004].
22. Sharma DC. India pressed to relax rules on clinical trials. Drug companies claim changes are essential, but crities fear Indian patients will become guinea pigs. Lancet 2004;363:1528-1529.
23. Richart RM, Sankaranarayanan R, Robles S, Wrighl TC, Jr. Cervical cancer screening strategies for developing countries. Contemp Ob Gyn 2001;1:71-79, 100-117.
24. Levin CE, Sellers JW. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam. Cancer 2002;94:2312-2314.
25. Sellers J. Response to Pap Screening in Developing Countries. Cervical-cancer-L archives. April. 2002. Available at: http://info.palh.org/cgi- bin/wa?Al=ind0204&L=cervical-cancer-1#7 [accessed on April 5, 2003].
26. Hartmann KE, Nanda K, Hall S, Myers E. Technologic advances for evaluation of cervical cytology: is newer better? Review. Obstet Gynecol Surv 2001;56:765-774.
27. Canadian Coordinating Office for Health Technology Assessment (CCOHTA). Assessment of techniques for cervical cancer screening. Report 1997: 2E. National Library of Canada, May 1997. ISBN 1-89551-49-3.
28. Australian Health Technology Advisory Committee (AHTAC). Review of automated and semi-automated cervical screening devices. AHTAC Publications approval No. 2416. Canberra:Common-wealth Department of Health and Family Services, April 1998. ISBN 0 642 36755 8.
29. Broadstock M. Effectiveness and cost-effectiveness of automated and semi-automated cervical screening devices: a systematic review of the literature. New Zealand Health Technology Assessment (NZHTA): the Clearing House for Health Outcomes and Health Technology Assessment. NZHTA Report 2000;3(1). Copies available at http://nzhta.chmeds.ac.nz.
30. Broadstock M. Cylopathology 2001;12:141-143 (abstracts).
31. McCrory DC, Mather DB, Baslian L, et al. Evaluation of cervical cytology. Evidence Report/Technology Assessment No. 5. Prepared by Duke Universily under Contract No. 290-97-0014. AHCPR Publication No. 99-E010. Rockville, MD: Agency for Healthcare Policy and Research. February 1999.
32. Sawaya GF, Grimes DA. New technologies in cervical cytology screening: a word of caution. Obstel Gynecol 1999;94:307-310.
33. Herrero R, Schiffman MH, Hildesheim A, et al. Is cervical cancer cylological screening valuable in developing countries? In: Franco E and Monsonego J, editors. New developments in cervical cancer screening and prevention. Oxford: Blackwell Sciences Ltd; 1997, p 241-249.
34. Belinson J. Qiao YL. Prelorius R. et al. Shanxi Province cervical cancer screening study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol 2001;83:439-444.
35. Hulchinson ML, Zahniser DJ. Sherman ME, et al. Utility of liquid-based cytology for cervical carcinoma screening: results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma. Cancer 1999;87:48-55.
36. Schiffman M. Herrero R, Hildesheim A, et al. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA 2000;283:87-93.
37. Denny L, Kuhn L, Pollack A. Wainwrighl H, Wrighl TC, Jr. Evaluation of allernalive methods of cervical cancer screening for resource-poor settings. Cancer 2000;89:826-833.
38. Womack SD, Chirenje ZM, Blumenthal PD, et al. Evaluation of a human papillomavirus assay in cervical screening in Zimbabwe. BJOG 2000;107:33-38.
39. University of Zimbabwe/JHPlEGO Cervical Cancer Project. Visual inspection with acetic acid for cervical cancer screening: test qualities in a primary care setting. Lancet 1999;353:869-873.
40. American College of Obstetrics and Gynecology (ACOG) Statement of Policy: Cervical cancer prevention in low-resource settings. Obstet Gynecol 2004;103:607-609.
41. Davey DD, Naryshkin S, Nielsen ML, et al. Atypical squamous cells of undetermined significance: interlaboratory comparison and quality assurance monitors. Diagn Cylopathol 1994;11:390-396.
42. Davey DD, Woodhouse S, Styer P, Stastny J, Mody D. Atypical epithelial cells and specimen adequacy. Arch Pathol Lab Med 2000;124:203-211.
43. Cuzick J, Szarewski A, Cubie H, et al. Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 2003;362:1871-1876.
44. Sawaya GF, Brown AD, Washington AE, Garber AM. Clinical practice. Current approaches to cervical-cancer screening. Review. N Engl J Med 2001;344:1603-1607.
45. United States Preventive Services Task Force. Guide to clinical preventive services, 2nd ed. Alexandria, VA: International Medical Publishing, Inc.; 1996.
46. United States Department of Health and Human Services.Smoking: issues in statistical and causal inference. In: The health consequences of smoking: A report of the surgeon general. Atlanta, GA: Centers for Disease Control and Prevention, Office on Smoking and Health; 2004. Available at: http://www.cdc.gov/tobacco/sgr/sgr_2004/chapters.htm [accessed June 8, 2004].
47. Sankaranarayanan R, Nene BM, Dinshaw K, et al. Early detection of cervical cancer with visual inspection methods: a summary of completed and on-going studies in India. Salud Publica Mex 2003;45(Suppl 3):S399-S407.
48. Lie RK, Emanuel E, Grady C, Wendler D. The standard of care debate: the Declaration of Helsinki versus the international consensus opinion. J Med Ethics 2004;30:190-193.
49. Lie RK. Ethics of placebo-controlled trials in developing countries. Bioethics 1998;12:307-311.
50. Schuklenk U. The standard of care debate: against the myth of an "international consensus opinion". J Med Ethics 2004;30:194-197.
51. Angell M. The ethics of clinical research in the Third World. N Engl J Med 1997;337:847-849.
52. Thomas SB, Quinn SC. The Tuskegee Syphilis Study, 1932 to 1972: implications for HIV education and AIDS risk education programs in the black community. Am J Public Health 1991;81:1498-1505.
53. Corbie-Smith G, Thomas SB, Williams MV, Moody-Ayers S. Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med 1999;14:537-546.
54. Pickle LW, Gillum RG. Geographic variation in cardiovascular disease mortality in US blacks and whites. J Nail Med Assoc 1999;91:545-556.
55. Miller AB. Quality assurance in screening strategies. Review. Virus Res 2002;89:295-299.
56. Berwick DM. Quality of health care. Part 5: payment by capitation and the quality of care. N Engl J Med 1996;335:1227-1231.
57. Institute of Medicine. In: Donaldson MS, editor. Measuring the quality of health care. Washington, DC: National Academy Press; 1999.